0000950170-24-070626.txt : 20240607 0000950170-24-070626.hdr.sgml : 20240607 20240607161008 ACCESSION NUMBER: 0000950170-24-070626 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240606 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kapur Anil CENTRAL INDEX KEY: 0001730703 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20859 FILM NUMBER: 241029458 MAIL ADDRESS: STREET 1: 275 MADISON AVE STREET 2: SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GERON CORP CENTRAL INDEX KEY: 0000886744 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 752287752 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6504737700 MAIL ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GERON CORPORATION DATE OF NAME CHANGE: 19960521 4 1 ownership.xml 4 X0508 4 2024-06-06 0000886744 GERON CORP GERN 0001730703 Kapur Anil C/O GERON CORPORATION 919 E HILLSDALE BLVD. SUITE 250 FOSTER CITY CA 94404 false true false false EVP, Corp Strategy & CCO false Employee Stock Option (right to buy) 1.43 2024-06-06 4 A false 250000 0 A 2029-12-01 Common Stock 250000 250000 D Performance-based stock option granted on December 2, 2019 and vested in full on June 6, 2024 upon approval of the NDA by the US FDA for imetelstat in lower risk MDS. /s/ Scott A. Samuels for Anil Kapur 2024-06-07